Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 4:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1561–1584 of 17,751 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: Excessive Sleepiness
Interventions: armodafinil, placebo; Drug
Lead sponsor: Cephalon; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 427 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 4
States / cities: Atlanta, Georgia • Crestview, Kentucky • New York, New York + 1 more

Conditions: Type 2 Diabetes Mellitus, Diabetic Peripheral Neuropathy
Interventions: Exenatide, Glargine; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 70 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Acne Vulgaris
Interventions: Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd), ACZONE® (dapsone) gel, 7.5% (Allergan, INC.), Placebo for Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd); Drug · Other
Lead sponsor: Torrent Pharmaceuticals Limited; Industry
Eligibility: 12 Years to 40 Years
Enrollment: 1,150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 11
States / cities: Sherman Oaks, California • Brandon, Florida • Miami, Florida + 7 more

Conditions: Plantar Fascitis
Interventions: Photobiomodulation Therapy (PBMT), Sham-Photobiomodualtion Therapy (Sham-PBMT); Device
Lead sponsor: The Geneva Foundation; Other
Eligibility: 18 Years to 64 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Tacoma, Washington

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Placebo ELLIPTA, Nemiralisib ELLIPTA 50 µg, Nemiralisib ELLIPTA 100 µg, Nemiralisib ELLIPTA 250 µg, Nemiralisib ELLIPTA 500 µg, Nemiralisib ELLIPTA 750 µg, Albuterol (Salbutamol) MDI or nebules, Standard of care therapy; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 943 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 21
States / cities: Mobile, Alabama • Colorado Springs, Colorado • Daytona Beach, Florida + 17 more

Conditions: Insomnia, Schizophrenia, Schizoaffective Disorder, Sleep Disorders
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Myopia, Visual Diet, Pupil, Viewing Distance, Illuminance, Wavelength, Vergence, Accommodative Facility
Interventions: Not listed
Lead sponsor: State University of New York College of Optometry; Other
Eligibility: 7 Years to 12 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: New York, New York

Conditions: Malaria
Interventions: VRC-MALMAB0100-00-AB, Plasmodium falciparum (P. falciparum) sporozoite challenge; Drug · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Baltimore, Maryland • Bethesda, Maryland

Conditions: PTSD
Interventions: Exposure Therapy; Behavioral
Lead sponsor: University of Central Florida; Other
Eligibility: 18 Years to 64 Years
Enrollment: 134 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Chronic Kidney Disease
Interventions: Finerenone (BAY94-8862), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 5,734 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 176
States / cities: Birmingham, Alabama • Fort Payne, Alabama • Huntsville, Alabama + 125 more

Conditions: Surgery
Interventions: Peanut Protein Powder, Standard Care by Surgeon and Physical Therapist; Dietary Supplement · Other
Lead sponsor: Auburn University; Other
Eligibility: 60 Years to 75 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Tracheostomy
Interventions: Early Tracheostomy Change; Procedure
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 0 Years to 2 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Postmenopausal Osteoporosis, Gut Microbiome, Menopause
Interventions: Blackcurrant (BC) extract, Placebo; Drug
Lead sponsor: University of Connecticut; Other
Eligibility: 45 Years to 70 Years · Female only
Enrollment: 159 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Storrs, Connecticut

Conditions: Cannabis Use, Delinquency
Interventions: Brief Family Based Intervention, Parenting Psychoeducation; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 12 Years to 16 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Breast Cancer, Cardiac Dysfunction
Interventions: Vericiguat, Optimal medical therapy; Drug · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: HIV
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1988 – 2030
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cognitive Dysfunction, Breast Cancer Survivors
Interventions: Exercise, Control; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 21 Years to 85 Years · Female only
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: La Jolla, California

Conditions: ADHD
Interventions: Fidget Device, Control group; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 6 Years to 13 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Cary, North Carolina

Conditions: Cerebral Palsy, Muscular Dystrophy, Spina Bifida, Incomplete Spinal Cord Injury
Interventions: EA-KAFO; Device
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 3 Years to 17 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Sleep, Parenting, Eating Behavior, Obesity
Interventions: Baby Sleep, Baby Care; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Congenital Heart Disease, Neurodevelopment, Executive Function, Working Memory Training, Infant Open-heart Surgery
Interventions: Cogmed Working Memory Training; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 13 Years to 16 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetes
Interventions: Diabetes group visit; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pulmonary Hypertension
Interventions: To discern micro-RNA specific for right and left heart induced PH; Diagnostic Test
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Liver Failure, Liver Diseases, Alcoholic, Liver Diseases, Pain, Postoperative, Transplant; Failure, Liver, Liver Cirrhosis, Biliary
Interventions: BRIDGE device; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder

Evaluation of Exenatide in Patients With Diabetic Neuropathy

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Low-Level Laser Therapy for Plantar Fasciitis

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia

Longitudinal Measurements of Visual Diet in Children

Trial to Evaluate CIS43LS in Healthy Adults

Effectiveness of Trauma Management Therapy and Prolonged Exposure Therapy

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

Peanut Protein Supplementation to Prevent Muscle Atrophy and Improve Recovery Following Total Knee Arthroplasty

Tracheostomy Change

Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females

Brief Family-Based Cannabis Use Intervention for Youth With Early Juvenile Justice Involvement

A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction

Collection of Blood for Multiple Collaborative Studies

Physical Activity and Neuropsychological Outcomes in a Cancer Population

Examining the Impacts of Fidget Technology on Attention in Children With ADHD

Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders

The Baby Care Study

Improving Neurodevelopment in Adolescents With Congenital Heart Disease

Implementing Diabetes Group Visits in Community Health Centers

Pulmonary Vascular Hemodynamics Before and After Mitral Valve Procedures

BRIDGE Device for Post-operative Pain Control